ATE274907T1 - Loratadin zur verwendung als antiarrhythmikum - Google Patents

Loratadin zur verwendung als antiarrhythmikum

Info

Publication number
ATE274907T1
ATE274907T1 AT99304375T AT99304375T ATE274907T1 AT E274907 T1 ATE274907 T1 AT E274907T1 AT 99304375 T AT99304375 T AT 99304375T AT 99304375 T AT99304375 T AT 99304375T AT E274907 T1 ATE274907 T1 AT E274907T1
Authority
AT
Austria
Prior art keywords
loratadine
antiarrhythmic
mammals
atrial fibrillation
treating atrial
Prior art date
Application number
AT99304375T
Other languages
English (en)
Inventor
Guy Buckland
Tilman Friedrich
Carol Ann Satler
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of ATE274907T1 publication Critical patent/ATE274907T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
AT99304375T 1998-06-30 1999-06-04 Loratadin zur verwendung als antiarrhythmikum ATE274907T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9124698P 1998-06-30 1998-06-30

Publications (1)

Publication Number Publication Date
ATE274907T1 true ATE274907T1 (de) 2004-09-15

Family

ID=22226786

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99304375T ATE274907T1 (de) 1998-06-30 1999-06-04 Loratadin zur verwendung als antiarrhythmikum

Country Status (10)

Country Link
US (1) US6110927A (de)
EP (1) EP0968715B1 (de)
JP (1) JP2000034231A (de)
AT (1) ATE274907T1 (de)
BR (1) BR9902393A (de)
CA (1) CA2276324C (de)
DE (1) DE69919789T2 (de)
DK (1) DK0968715T3 (de)
ES (1) ES2226289T3 (de)
PT (1) PT968715E (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
AU2002256967A1 (en) * 2000-10-30 2002-09-12 Schering Corporation Treating or reducing the risk of cardiovascular disease
US6544557B2 (en) 2001-01-09 2003-04-08 Pan Pharmaceutical Limited Effervescent tablet compositions
US6720002B2 (en) 2001-07-20 2004-04-13 R.P. Scherer Technologies, Inc. Antihistamine formulations for soft capsule dosage forms
CA2690490C (en) 2010-01-19 2012-06-26 Accucaps Industries Limited Pharmaceutical formulations of loratadine for encapsulation and combinations thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4282233B1 (en) * 1980-06-19 2000-09-05 Schering Corp Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines
HU194864B (en) * 1984-02-15 1988-03-28 Schering Corp Process for production of 8-chlor-6,11-dihydro-11-(4-piperidilidene)-5h-benzo (5,6)-cyclo-hepta (1,2-b) pyridine and its salts
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Also Published As

Publication number Publication date
EP0968715B1 (de) 2004-09-01
CA2276324C (en) 2003-08-19
ES2226289T3 (es) 2005-03-16
DE69919789D1 (de) 2004-10-07
PT968715E (pt) 2004-12-31
US6110927A (en) 2000-08-29
DE69919789T2 (de) 2005-09-08
DK0968715T3 (da) 2004-12-27
EP0968715A1 (de) 2000-01-05
BR9902393A (pt) 2000-05-02
CA2276324A1 (en) 1999-12-30
JP2000034231A (ja) 2000-02-02

Similar Documents

Publication Publication Date Title
PT939767E (pt) Factor viii porcino e seus hibridos
DE69709035D1 (de) Kathodenbefestigung für eine Ionenquelle mit indirekt geheizter Kathode
DE19780533T1 (de) Bohrerführung zur Verwendung beim Plazieren von dentalen Implantaten
DE69733412D1 (de) Verschlussvorrichtung zur reparatur von körperlichen defektöffnungen
DE69535671D1 (de) Verfahren und System zur Kanalvergabe unter Verwendung von Leistungsregelung und Mobil-Unterstützten Weiterreichen-Messungen
DE69428284T2 (de) Verfahren zur herstellung von verbundenen wafern unter verwendung von diamant als isolator
DE69704652D1 (de) Anordnung zur Durchführung von Augenoperationen
DE69837044D1 (de) Verfahren und Vorrichtung zur Versorgung von orthogonalen Strahlenbündeln, Sektoren und Picozellen
DE69806155T2 (de) Verfahren zur epoxidierung von olefinen mit wasserstoffperoxid
NO990449D0 (no) FremgangsmÕte for hydrogenbehandling
DE69812418D1 (de) Verfahren zur herstellung von wasserstoffperoxid
DE69528992D1 (de) Verwendung von aromatischen halogenverbindungen zur behandlung der zellproliferation in säugetieren
ATE274907T1 (de) Loratadin zur verwendung als antiarrhythmikum
BR9007356A (pt) Aparelho e processo para reducao de fendimento de isolamento de poliolefina em cabos
DE69325452D1 (de) Verfahren zur herstellung von (s)-3-amino-1-substituiert-pirrolidine
GB9713673D0 (en) Method for operating an oxygen probe
DE59704252D1 (de) Vorrichtung zur erzeugung von eisenschwamm
DE69514466D1 (de) Modulationsregelung für eine Wechselstrommaschine
DE69429981T2 (de) Verfahren zur Verstärkung von hochfrequenten Strömen mittels MOSFET-Elementen
IL126162A0 (en) Method for treating bipolar disorder
DE59702788D1 (de) Verfahren zur herstellung von 4,6-diamino-resorcin-dihydrochlorid
DE59909422D1 (de) Verfarhen zum betreiben von peripheriebaugruppen innerhalb einer atm-kommunikationseinrichtung
DE59702513D1 (de) Verfahren zur herstellung von linearen blockcopolymeren
DE59807019D1 (de) Verfahren zur herstellung von aromatischen bisimiden
ITBO970590A0 (it) Procedimento di invecchiamento naturale per trattare pelli e tessuti e relativa apparecchiatura.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0968715

Country of ref document: EP

REN Ceased due to non-payment of the annual fee